Patient Safety
16 articles on Patient Safety, written by Shotlee and medically reviewed for clinical accuracy.
DIY Weight Loss Injections: The Dangerous Rise of 'Skinny Jabs'
As the cost of popular weight loss medications like Mounjaro and Wegovy climbs, a growing number of individuals are resorting to dangerous, unapproved DIY 'skinny jabs' sourced illegally online. This article delves into the risks, motivations, and the alarming reality of this trend.
7 min read
GLP-1 Overdose Leads to Severe Diarrhea: A Warning
A man's harrowing experience with extreme diarrhea after overdosing on an experimental GLP-1 drug, retatrutide, serves as a stark reminder of the risks associated with obtaining and using unapproved medications outside of medical supervision. This article delves into the case, the science behind these powerful weight loss drugs, and the importance of regulated healthcare.
7 min read
GLP-1 Medications: Understanding Drug Interactions and Safety
GLP-1 receptor agonists are powerful tools for managing diabetes and obesity, but understanding their potential interactions with other medications is crucial for patient safety and treatment efficacy.
7 min read
Peptide Panic: Why 'Plateau Panic' Hits Hard When Suppliers Disappear
The abrupt closure of a major peptide supplier has sent shockwaves through the patient community, revealing the inherent risks of gray-market access and highlighting the critical need for regulated, physician-guided peptide therapy.
8 min read
Health Canada Warns Against Buying Peptides Online—CBC News Buys Them Easily
Health Canada recently warned Canadians not to buy or use unauthorized injectable peptide drugs amid reports of adverse reactions. Yet CBC News effortlessly purchased three such products online from different sellers. Experts highlight serious risks and contrast them with regulated GLP-1 medications like Ozempic and Wegovy.
5 min read
Time for Guardrails on GLP-1 Compounding: Safety Risks Exposed
America faces a crisis in unregulated compounded GLP-1 drugs, with FDA reporting 1,150 adverse events including hospitalizations and deaths. Exploiting shortages of semaglutide and tirzepatide, compounders flood the market with untested products, misleading consumers. Now, with the SAFE Drugs Act and FDA crackdowns, it's time to restore safety standards.
4 min read
MHRA Investigates UK Peptide Clinics Over Health Claims
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is probing peptide clinics for unlawful health claims on experimental therapies. A Guardian investigation uncovered websites touting benefits like tissue repair from BPC-157 despite scant human evidence. Clinics defend their practices amid rising interest in these injections.
5 min read
DCGI Intensifies Crackdown on Unauthorized GLP-1 Weight-Loss Drug Sales
India's DCGI is cracking down harder on the unauthorized sale of GLP-1 weight-loss drugs amid rising generic variants. Inspections at online pharmacies, wholesalers, and clinics aim to prevent misuse that could lead to serious health risks. Patients must seek prescriptions only from qualified endocrinologists or specialists.
4 min read
Safety Signals Matter as Semaglutide Scales in India
Semaglutide's patent expiry in India has flooded the market with affordable generics, dropping prices from over ₹10,000 to as low as ₹1,300 per month. While this opens access for millions with Type 2 diabetes and obesity, experts warn of safety risks from misuse without proper guidance. Discover the implications for patients and the growing market.
5 min read
Weight Loss Injections Side Effects Affect 1 in 10 Users
Weight loss injections such as Mounjaro and Wegovy, popular GLP-1 inhibitors, come with side effects impacting one in 10 users, primarily digestive issues like nausea and diarrhea. The British Heart Foundation highlights risks including pancreatitis, vision loss, and nutritional deficiencies. Understanding these helps patients manage treatment safely.
5 min read
NC Poison Control Warns GLP-1 Users to Use Caution
North Carolina Poison Control is alerting GLP-1 users to watch for common dosing mistakes after averaging one to two calls daily last year. With 80% involving administration errors for drugs like Ozempic, Wegovy, and Mounjaro, most cases were mild but highlight real risks. Discover symptoms, prevention strategies, and FDA advice on compounded GLP-1 drugs.
5 min read
UK Mounjaro Warning: Counterfeit Pens – Check Batch Numbers
The UK's MHRA has issued a critical warning about counterfeit Mounjaro pens following reports from Eli Lilly. These fake pens contain tirzepatide but may not be sterile, posing potential health risks. Patients are urged to verify batch numbers and report suspicions to the Yellow Card scheme.
5 min read
Hims & Hers Shares Sink 16% as FDA Halts Wegovy Copycat Pill
Hims & Hers Health Inc. (HIMS) has halted sales of its copycat Wegovy weight loss pill just two days after launch, leading to a 16% plunge in shares amid FDA warnings and Novo Nordisk threats. This marks a regulatory pivot as GLP-1 shortages ease. Patients and investors should note the growing scrutiny on compounded versions of popular drugs like Wegovy.
5 min read
GLP-1 Drugs and Eating Disorders: Risks of Telehealth Prescribing
A woman's relapse into an eating disorder after online prescription of GLP-1 drugs highlights growing concerns about telehealth practices. Experts from the Royal College of GPs warn of safety gaps, urging caution with these powerful medications. Discover the science, risks, and best practices for safe use.
4 min read
GLP-1 Warning: Pancreatitis Risk with Ozempic, Wegovy, Mounjaro
The MHRA has updated warnings for GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, highlighting a rare but serious risk of acute pancreatitis. With 1.6 million UK users in the past year, knowing the symptoms of severe abdominal pain radiating to the back is crucial. This guide breaks down the science, risks, and steps for safe use.
4 min read
GLP-1 Side Effects & Lawsuits: What Users Must Know
GLP-1 medications like Ozempic and Wegovy have transformed weight management, but rising lawsuits highlight serious side effects like gastroparesis and vision loss. This guide breaks down the science, risks, and strategies for safe use. Learn how to monitor symptoms and integrate lifestyle changes effectively.
4 min read